Product Description: Izorlisib (CH5132799) is a selective class I PI3K inhibitor. Izorlisib inhibits class I PI3Ks, particularly PI3Kα, with an IC50 of 14 nM.
Applications: Cancer-Kinase/protease
Formula: C15H19N7O3S
References: [1]Tanaka H, et al. The selective class I PI3K inhibitor CH5132799 targets human cancers harboring oncogenic PIK3CA mutations. Clin Cancer Res, 2011, 17(10), 3272-3281./[2]Ohwada J, et al. Discovery and biological activity of a novel class I PI3K inhibitor, CH5132799. Bioorg Med Chem Leff, 2011, 21(6), 1767-1772.
CAS Number: 1007207-67-1
Molecular Weight: 377.42
Compound Purity: 99.01
Research Area: Cancer
Solubility: DMSO : 4.55 mg/mL (ultrasonic)
Target: PI3K